Firms

Lynx Financial

Lynx Financial is a Shanghai-based healthcare and life-science investment and financial-advisory firm operating under the Chinese brand 德石资本. It invests in therapeutics and medical technologies and helps companies connect with financial and strategic partners across China and international markets. Its advisory work includes cross-border licensing, mergers and acquisitions, private placements and IPOs. Its own site documents investments and partnerships in companies including Aurealis Therapeutics and Bone Index; Marginum’s issuer announcement confirms Lynx as a new investor in its 2025 pre-Series A financing. The business combines capital investment with transaction advice, so an advisory mandate is not automatically treated as an investment.

Founded: —
Type: Venture capital